Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000891839-20-000253
Filing Date
2020-09-01
Accepted
2020-09-01 16:22:48
Documents
2
Period of Report
2020-09-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1605
2 attachment_1.txt EX-24 2861
  Complete submission text file 0000891839-20-000253.txt   5847
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Issuer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1895 MT HOPE AVENUE ROCHESTER NY 14620
Business Address
Scala Robert (Reporting) CIK: 0001822706 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38624 | Film No.: 201154684